Tech, pharma, biotech killer acquisitions prompted expanded powers, EU merger chief says
Technology, pharmaceutical and bio-tech companies' acquisitions of tiny but innovative challengers have created "unease" at the EU's merger regulator, the bloc's competition boss said today as she outlined an expansion to...To view the full article, register now.
Already a subscriber? Click here to view full article